Attenuated swine fever virus live marker vaccine strain and vaccine composition for oral administration using same
A technique of live attenuated vaccine and swine fever virus, which is applied in the field of the attenuated swine fever virus labeled live vaccine strain and the vaccine composition for oral administration using the same, and can solve the problem that it is difficult for pigs to distinguish infection antibodies from field strains, Serological identification and other issues, to achieve the effects of enhanced safety, alleviation of side effects, and excellent effects
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0062] [Example 1] Preparation of attenuated classical swine fever virus marker live vaccine strain CSFV BErns attenuated C-P50
Embodiment 1-1
[0063] [Example 1-1] Cultivating Flc-LOM-Berns virus in CPK cells
[0064] Flc-LOM-Berns virus strain (deposit number: KCTC12304BP) was first prepared by the method described in Korean Laid-Open Patent No. 2010-0121288. In order to increase the titer and attenuate the Flc-LOM-Berns virus, the cells used to subculture the virus were explored. As a result of multiple experiments, compared with PK cells (porcine kidney cells, porcine kidney cells) and BK cells (bovine kidney cells, bovine kidney cells), in CPK cells (cloned porcine kidney cells, cloned porcine kidney cells) The CSFV-marked live virus can be obtained more effectively during infection and subculture, so CPK cells were selected as the first cells to be subcultured.
[0065] In order to further improve the titer of the Flc-LOM-BErns virus, first, the mycoplasma that contaminates the prepared Flc-LOM-BErns virus is removed by the following method. First, add MRA (Mycoplasma removal agent (Mycoplasma removal agent), ...
Embodiment 1-2
[0081] [Example 1-2] Continuous subculture in BK cells, PK cells and CPK cells
[0082] In order to increase the titer of the virus propagated to the 20th generation by culturing in the CPK cells of Example 1-1, in BK cells, the same culture conditions as in Example 1-1 were carried out again from the 21st generation to the 30th generation. Generations of continuous culture, the resulting titer from 1 × 10 3.5 TCID 50 / ml increased by 1×10 1.0 TCID 50 / ml and reached 1×10 4.5 TCID 50 / ml. Afterwards, in PK cells again, with the same culture condition as in Example 1-1, proliferate from the 31st generation to the 40th generation, as a result, the titer ranges from 1×10 4.5 TCID 50 / ml increased by 1×10 1.0 TCID 50 / ml and reached 1×10 5.5 TCID 50 / ml. Finally, go back to CPK cells again, and propagate from 41 generations to 50 generations with the same culture conditions as in Example 1-1, and the resulting titer ranges from 1×10 5.5 TCID 50 / ml increased by 1×10 ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap